In a significant boost to India’s growing healthtech landscape, Luma Fertility, a fertility-focused startup, has raised $4 million in a seed funding round led by Surge, the early-stage platform of Peak XV Partners (formerly Sequoia India & Southeast Asia). The round also saw participation from notable investors including Ameera Shah, executive director of Metropolis Healthcare, and Vijay Taparia, chairman of B2V Ventures.
Founded in 2024 by Neha Motwani, Luma Fertility was born out of her personal struggle with infertility. Drawing from her own experience and conversations with hundreds of women, Motwani realized the urgent need for a patient-centric approach to fertility care in India. She launched Luma to offer modern, compassionate, and tech-enabled fertility solutions that focus on the individual rather than a one-size-fits-all system.
“From my own experience and after speaking to hundreds of women, it became clear that fertility care in India is broken. It’s optimised for systems, not people. At Luma, we’ve rebuilt it from the ground up—designed entirely around the patient,” said Motwani.
Expansion Plans and Market Opportunity
Luma Fertility currently operates a single clinic in Mumbai but has ambitious plans to scale. With the newly raised funds, the startup aims to expand its footprint across major metro cities, targeting the launch of 50 fertility clinics in the coming years. The capital will be used for clinic expansion, hiring medical talent, investing in proprietary technology, and enhancing the overall patient experience.
The funding comes at a crucial time when infertility is becoming a pressing health issue in India. Over 33 million couples in the country face fertility challenges, affecting both men and women. The demand for IVF and other fertility treatments is surging, with the market projected to grow to $5 billion by 2033.
Backing from Seasoned Investors
The involvement of Surge by Peak XV Partners underscores investor confidence in the startup’s vision and the larger opportunity in fertility-focused healthtech. Surge has a strong track record of supporting disruptive early-stage companies in sectors ranging from consumer tech to healthcare.
Investor Ameera Shah, a prominent name in India’s diagnostic and health services sector, brings deep domain expertise and strategic insight to the table. Similarly, Vijay Taparia’s backing through B2V Ventures adds further credibility to Luma’s growth potential.
A New Era for Fertility Health in India
Luma Fertility enters a sector ripe for disruption, where legacy IVF clinics often fall short in transparency, patient care, and trust. By building a technology-driven, empathy-first healthcare model, Luma aims to transform the fertility journey for millions of Indians.
As India’s healthtech space continues to evolve, startups like Luma Fertility are not only meeting critical healthcare needs but also reshaping the way care is delivered—making it more accessible, humane, and effective.
Leave a comment